IBA (Ion Beam Applications S.A., EURONEXT) announced it has signed a contract with Istituto Clinico Humanitas (Humanitas Research Hospital) for the installation of a Proteus®ONE1 compact proton therapy solution in Rozzano (Milan), Italy. IBA will start to recognize the revenue of this contract in 2022. The proton therapy solution will be installed at the Humanitas Cancer Center and includes a Proteus®ONE solution as well as a fully integrated quality assurance (QA) hardware and software package from IBA Dosimetry.

The contract includes long-term operation and maintenance services to be provided by IBA. Istituto Clinico Humanitas expects to start treating patients by 2025. The typical end-user price for a Proteus®ONE system with a 10-year maintenance contract ranges between EUR 35-45 million.